about
Interferon-λ: Immune Functions at Barrier Surfaces and BeyondThe virome in host health and diseaseDiscovery of a proteinaceous cellular receptor for a norovirusNorovirus immunology: Of mice and mechanismsNorovirus Regulation by Host and Microbe.Norovirus drug candidates that inhibit viral capsid attachment to human histo-blood group antigens.Association between enteropathogens and malnutrition in children aged 6-23 mo in Bangladesh: a case-control study.Comparative genome analysis of a norovirus GII.4 strain GZ2013-L10 isolated from South China.Case-Case Analysis Using 7 Years of Travelers' Diarrhea Surveillance Data: Preventive and Travel Medicine Applications in Cusco, Peru.Norovirus-Mediated Modification of the Translational Landscape via Virus and Host-Induced Cleavage of Translation Initiation Factors.Interferon-Lambda: A Potent Regulator of Intestinal Viral Infections.Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity.A novel reverse genetics system for human norovirusMurine norovirus 1 (MNV1) replication induces translational control of the host by regulating eIF4E activity during infectionCommensal microbes and interferon-λ determine persistence of enteric murine norovirus infection.A working model of how noroviruses infect the intestineIdentification of a novel cellular target and a co-factor for norovirus infection - B cells & commensal bacteria.Repurposing of rutin for the inhibition of norovirus replication.Molecular chaperone Hsp90 is a therapeutic target for norovirusesInfection of Murine Macrophages by Salmonella enterica Serovar Heidelberg Blocks Murine Norovirus Infectivity and Virus-induced Apoptosis.Viral immunity. Transkingdom control of viral infection and immunity in the mammalian intestine.Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectivesHuman norovirus binding to select bacteria representative of the human gut microbiota.Current Status of Norovirus Infections in Children in Sub-Saharan Africa.Oral Norovirus Infection Is Blocked in Mice Lacking Peyer's Patches and Mature M Cells.Regulation of Norovirus Virulence by the VP1 Protruding Domain Correlates with B Cell Infection Efficiency.Enterobacter cloacae inhibits human norovirus infectivity in gnotobiotic pigs.Increased and prolonged human norovirus infection in RAG2/IL2RG deficient gnotobiotic pigs with severe combined immunodeficiency.Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB.Anti-viral Effect of Bifidobacterium adolescentis against Noroviruses.Anti-norovirus therapeutics: a patent review (2010-2015).Recent Advances in the Discovery of Norovirus Therapeutics.The molecular pathology of noroviruses.Functions of the 5' and 3' ends of calicivirus genomes.Thermal Inactivation of Foodborne Enteric Viruses and Their Viral Surrogates in Foods.Norovirus mechanisms of immune antagonism.Infection models of human norovirus: challenges and recent progress.Histologic Lesions Induced by Murine Norovirus Infection in Laboratory Mice.Expression of Ifnlr1 on Intestinal Epithelial Cells Is Critical to the Antiviral Effects of Interferon Lambda against Norovirus and Reovirus.Minimizing Bias in Virally Seeded Water Treatment Studies: Evaluation of Optimal Bacteriophage and Mammalian Virus Preparation Methodologies.
P2860
Q26801049-7A4D2469-0037-4041-B6E8-DFD918E51E5DQ26824795-2D78B2D2-F169-42BD-9EC6-25D3ABE0A7ACQ27727711-03688B18-13B2-4666-BC17-54DAFE8A3895Q28083087-9D19C61E-D33D-45F7-AFC0-8F2553B8F6DDQ30240631-D1436130-2D0D-4EC4-8496-14FC04F68209Q30248992-FCA577EE-AA8B-4966-9C43-BDB31FF6126DQ30252712-C6697539-ADD2-4228-996B-97A831BDC12DQ30383126-8D4A5D76-2589-4B40-98E0-D0DA3379398BQ31159975-4BB3FC51-A436-4AA3-900B-0F0E4CDDA4A8Q33569848-BA7C0B88-F797-4E05-936B-0BFBDAEBF288Q33854465-7F54A378-045B-4D01-B660-9FC0A7582E32Q34449976-99F88B55-6B70-4E34-B228-554132C4B67BQ34625561-CE3856B3-6A0B-40CB-ABD5-4E13ED754563Q35103915-4A1C8CC0-8EFA-4E3A-B4FB-7D8FFCCC5068Q35458229-74AFD785-7224-46B2-AA10-B60DBB8B8197Q35568903-0FD851CF-C99E-4703-9328-4ED8B98609C2Q35638367-1BB25E7E-20AA-4ED5-91CE-9737696AB0EBQ35674963-8DCF24C2-CE1E-4982-AA7A-D0E146DB6681Q35760516-8419DAA3-BDE8-4802-8F9D-431D4D3C55F7Q35867080-E0DC2925-7DAE-49FD-9940-0D6812A58917Q35905803-34EB7025-7124-414F-918D-C4E670B33CAFQ36275589-C350D635-1F32-4CF1-A494-70B2955986DDQ36296722-D13676FB-618D-41A8-A203-E3513D2D21DFQ36328925-BC697422-1546-4BF3-8A45-0CBA7E480C57Q36481488-A57D32C5-D830-4D4E-A7F8-189C2A20FB5EQ36736602-C2BD41D9-7196-4FF2-96E3-945FBCD7DC6DQ36835594-D94FA9F4-DABB-4D21-B1D4-9E44A23121E0Q36841045-5234AC8C-D69A-4647-BE57-AC46BCF8CF38Q36907013-6C6C7ACB-3CEF-4EF1-8103-A4A678F81747Q36978696-0C17E09C-353C-4527-B337-5C7113EE98D1Q37101808-C4FF78C8-A70D-4FDC-8505-3523A22CFB6AQ37517465-360D410F-7D8F-4797-BC1D-A3D5EC4958F8Q38259875-43D9D239-ED58-4F89-9162-CB063C7A2DF0Q38354315-E3FCBF78-5B34-4798-8E4A-F87BE61864F2Q38556232-EDBB78D3-BC81-4582-80B2-2854E32E4B95Q38670949-B72C6146-2307-4451-B54A-67C0430CA8E2Q38701344-F7E6DCDE-2414-4337-A368-2317FA2B3112Q38705235-515786EE-F306-4055-A959-E9236E3CA221Q38721800-B7033D8C-CF3A-4F85-A751-A9B120347C3AQ38724855-01A184B9-D9D4-4C2F-BC5D-E31292599775
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Advances in norovirus biology
@ast
Advances in norovirus biology
@en
Advances in norovirus biology
@nl
type
label
Advances in norovirus biology
@ast
Advances in norovirus biology
@en
Advances in norovirus biology
@nl
prefLabel
Advances in norovirus biology
@ast
Advances in norovirus biology
@en
Advances in norovirus biology
@nl
P2093
P2860
P3181
P1433
P1476
Advances in norovirus biology
@en
P2093
Herbert W Virgin
Kim Y Green
Stephanie M Karst
P2860
P304
P3181
P356
10.1016/J.CHOM.2014.05.015
P407
P577
2014-06-01T00:00:00Z